Physician profile
Benjamin Grear
NPI 1922214923
$5,473.66
in general payments reported to CMS, 2019-2025
11 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,622 · 2021: $1,453 · 2022: $489 · 2023: $185 · 2024: $595 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $2,190.55 | 2019-2025 | |
| Arthrex, INC. | $1,933.79 | 2019-2021 | |
| Stryker Corporation | $622.07 | 2021-2024 | Easyfuse, Inbone, Infinity |
| Crossroads Extremity Systems, LLC | $169.13 | 2019 | |
| Depuy Synthes Sales INC. | $141.29 | 2022 | |
| Treace Medical Concepts, INC. | $134.47 | 2022 | |
| Sanara Medtech INC. | $92.86 | 2024 | Celleraterx |
| Djo, LLC | $70.40 | 2025 | Cmf |
| Integra Lifesciences Corporation | $55.37 | 2019 | |
| Wright Medical Technology, INC. | $42.47 | 2019 | |
| Kerecis Limited | $21.26 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Grear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.